S Weit
Overview
Explore the profile of S Weit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naumann U, Huang H, Wolburg H, Wischhusen J, Weit S, Ohgaki H, et al.
Cancer Gene Ther
. 2005 Nov;
13(5):469-78.
PMID: 16276348
Chimeric tumor suppressor-1 (CTS-1) is based on the sequence of p53 and was designed as a therapeutic tool resisting various mechanisms of p53 inactivation. We previously reported that an adenovirus...
2.
Naumann U, Wischhusen J, Weit S, Rieger J, Wolburg H, Massing U, et al.
Cell Death Differ
. 2004 Sep;
11(12):1326-41.
PMID: 15389288
Alkylphosphocholines (APC) are candidate anticancer agents. We here report that APC induce the formation of large vacuoles and typical features of apoptosis in human glioma cell lines, but not in...
3.
Naumann U, Weit S, Wischhusen J, Weller M
FEBS Lett
. 2001 Sep;
505(1):23-6.
PMID: 11557035
Diva is a novel proapoptotic member of the Bcl-2 protein family which binds apoptosis activating factor-1 (APAF-1). Diva is identical with Boo which was identified as a novel antiapoptotic Bcl-2...
4.
Naumann U, Weit S, Rieger L, Meyermann R, Weller M
Biochem Biophys Res Commun
. 1999 Aug;
261(3):890-6.
PMID: 10441521
The cell cycle regulatory protein p27, an inhibitor of cyclin-dependent kinases (CDK), has been attributed a role in (i) prognosis in breast and colon cancer, (ii) induction of apoptosis in...